Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer

Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309

Mashima, 2009, De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy, Br J Cancer, 100, 1369, 10.1038/sj.bjc.6605007

Furuta, 2010, Metabolic genes in cancer: their roles in tumor progression and clinical implications, Biochim Biophys Acta, 1805, 141

Wellen, 2009, ATP-citrate lyase links cellular metabolism to histone acetylation, Science, 324, 1076, 10.1126/science.1164097

Hatzivassiliou, 2005, ATP citrate lyase inhibition can suppress tumor cell growth, Cancer Cell, 8, 311, 10.1016/j.ccr.2005.09.008

Bauer, 2005, ATP citrate lyase is an important component of cell growth and transformation, Oncogene, 24, 6314, 10.1038/sj.onc.1208773

Migita, 2008, ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer, Cancer Res, 68, 8547, 10.1158/0008-5472.CAN-08-1235

Beckner, 2010, Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas, Int J Cancer, 126, 2282, 10.1002/ijc.24918

Zhou, 2007, Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells, Cancer Res, 67, 2964, 10.1158/0008-5472.CAN-06-3439

Iorio, 2005, Alterations of choline phospholipid metabolism in ovarian tumor progression, Cancer Res, 65, 9369, 10.1158/0008-5472.CAN-05-1146

Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat Protoc, 3, 1101, 10.1038/nprot.2008.73

Kuhajda, 2000, Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology, Nutrition, 16, 202, 10.1016/S0899-9007(99)00266-X

Ookhtens, 1984, Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor, Am J Physiol, 247, R146

Swinnen, 2006, Increassed lipogenesis in cancer cells: new players, novel target, Curr Opin Clin Nutr Metab Care, 9, 358, 10.1097/01.mco.0000232894.28674.30

Pelicano, 2006, Glycolysis inhibition for anticancer treatment, Oncogene, 25, 4633, 10.1038/sj.onc.1209597

Luo, 2003, Targeting the PI3K-Akt pathway in human cancer: rationale and promise, Cancer Cell, 4, 257, 10.1016/S1535-6108(03)00248-4

Mazzoletti, 2010, PI3K/AKT/mTOR inhibitors in ovarian cancer, Curr Med Chem, 17, 4433, 10.2174/092986710794182999

Fresno Vara, 2004, PI3K/Akt signalling pathway and cancer, Cancer Treat Rev, 30, 193, 10.1016/j.ctrv.2003.07.007

Bababeygy, 2009, HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model, Anticancer Res, 29, 4901

Relja, 2010, Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells, Int J Mol Med, 26, 735, 10.3892/ijmm_00000520

Walter, 2009, Serum fatty acid synthase as a marker of pancreatic neoplasia, Cancer Epidemiol Biomarkers Prev, 18, 2380, 10.1158/1055-9965.EPI-09-0144

Migita, 2009, Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer, J Natl Cancer Inst, 101, 519, 10.1093/jnci/djp030

Hilvo, 2011, Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression, Cancer Res, 71, 3236, 10.1158/0008-5472.CAN-10-3894

Wang, 2009, Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis, Biochem Biophys Res Commun, 385, 302, 10.1016/j.bbrc.2009.05.045

Turyn, 2003, Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer, Horm Metab Res, 35, 565, 10.1055/s-2003-43500

Szutowicz, 1979, Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast, Br J Cancer, 39, 681, 10.1038/bjc.1979.120

Yahagi, 2005, Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma, Eur J Cancer, 41, 1316, 10.1016/j.ejca.2004.12.037

Varis, 2002, Targets of gene amplification and overexpression at 17q in gastric cancer, Cancer Res, 62, 2625

Moon, 2000, The roles of sterol regulatory element-binding proteins in the transactivation of the rat ATP citrate-lyase promoter, J Biol Chem, 275, 30280, 10.1074/jbc.M001066200

Sato, 2000, Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins, J Biol Chem, 275, 12497, 10.1074/jbc.275.17.12497